Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04230109
Title Sacituzumab Govitecan In TNBC (NeoSTAR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aditya Bardia
Indications

triple-receptor negative breast cancer

Therapies

Sacituzumab govitecan-hziy

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Recruiting Boston Massachusetts 02115 United States Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02115 United States Details
Massachusetts General Hospital - North Shore Cancer Center Recruiting Danvers Massachusetts 01923 United States Details
Massachusetts General Hospital at Newton-Wellesley Hospital Recruiting Newton Massachusetts 02462 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field